Glucose Monitoring Devices Market
Glucose Monitoring Devices Market - Global Industry Assessment & Forecast
#
Pages:
215
2024
Oct - 2024
VMR-3020
Segments Covered
By
Diabetes Type Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
-
By
Product Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Systems, Flash Glucose Monitoring Systems, Smartphone Apps, Wearables
-
By
End-Use Hospitals, Clinics, Home Care Settings, Diagnostic Centers
-
By
Distribution Channel Retail Sales, Institutional Sales
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2024 |
| Forecast
Years:
|
2025 - 2034 |
 Historical
Years:
|
2019 - 2023 |
 Revenue
2024: |
USD 15.67 Billion |
 Revenue 2034:
|
USD 44.88 Billion |
 Revenue CAGR
(2025 - 2034): |
11.1% |
Fastest Growing Region (2025 -
2034)
|
Asia Pacific |
Largest Region (2024):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2019 to 2023 |
| 3. | Forecast Data | 2025 to 2034 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 05-Nov-2024
FAQ
Frequently Asked Question
What is the global demand for Glucose Monitoring Devices in terms of revenue?
-
The global Glucose Monitoring Devices valued at USD 15.67 Billion in 2024 and is expected to reach USD 44.88 Billion in 2034 growing at a CAGR of 11.1%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, Dexcom Inc., Medtronic PLC, Roche Holding AG, LifeScan Inc., Senseonics Holdings, Inc., Ascensia Diabetes Care, Arkray Inc., Sinocare Inc., Menarini Diagnostics S.r.l, Ypsomed AG, Nemaura Medical Inc., i-Sens Inc., Medtrum Technologies, Omron Healthcare Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.1% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Glucose Monitoring Devices include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Glucose Monitoring Devices in 2024.
